AbbVie (ABBV) Selling, General & Administrative (2012 - 2026)
AbbVie's Selling, General & Administrative came in at $3.63 billion for Q2 2026, up 11.7% from $3.25 billion a year earlier and up 1.5% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Selling, General & Administrative (2012 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, AbbVie reported Selling, General & Administrative of $14.67 billion, up 0.5% year-over-year; for FY2025, it was $14.01 billion, down 5.0% from FY2024.
- Selling, General & Administrative carries a five-year compound annual growth rate of 4.4% (FY2020 to FY2025).
- Going back by year, Selling, General & Administrative was $14.75 billion in FY2024 (+14.6%), $12.87 billion in FY2023 (-15.6%), $15.26 billion in FY2022 (+23.6%) and $12.35 billion in FY2021 (+9.3%).
- The five-year range for quarterly Selling, General & Administrative is $3.04 billion (Q1 2023) to $5.41 billion (Q2 2022).
- Year-over-year, Selling, General & Administrative has increased for three consecutive quarters, with growth averaging 5.9% over the last eight quarters.
- The fastest year-over-year change in Selling, General & Administrative over five years came in Q2 2022 (growth of 71.0%), and the weakest in Q2 2023 (a decline of 39.6%).
- Business Quant data shows ABBV's Selling, General & Administrative at $3.58 billion (Q1 2026), $3.9 billion (Q4 2025) and $3.57 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Vertex Pharmaceuticals | 129.23 Bn | 101.23 Bn | 2.84 Bn | 582.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.63 Bn |
| Mar 31, 2026 | 3.58 Bn |
| Dec 31, 2025 | 3.90 Bn |
| Sep 30, 2025 | 3.57 Bn |
| Jun 30, 2025 | 3.25 Bn |
| Mar 31, 2025 | 3.29 Bn |
| Dec 31, 2024 | 3.86 Bn |
| Sep 30, 2024 | 4.21 Bn |
| Jun 30, 2024 | 3.38 Bn |
| Mar 31, 2024 | 3.32 Bn |
| Dec 31, 2023 | 3.19 Bn |
| Sep 30, 2023 | 3.37 Bn |
| Jun 30, 2023 | 3.27 Bn |
| Mar 31, 2023 | 3.04 Bn |
| Dec 31, 2022 | 3.42 Bn |
| Sep 30, 2022 | 3.30 Bn |
| Jun 30, 2022 | 5.41 Bn |
| Mar 31, 2022 | 3.13 Bn |
| Dec 31, 2021 | 3.26 Bn |
| Sep 30, 2021 | 3.08 Bn |
API Access
AbbVie Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();